Erratum to: Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells
Cell Communication and Signaling volume 14, Article number: 7 (2016)
Unfortunately, after publication of this article  it was noticed that 2 authors were not listed. The corrected author list can be seen above and the corrected Authors’ Contributions and Acknowledgements sections are included below.
Skolekova S, Matuskova M, Bohac M, Toro L, Demkova L, Gursky J, Kucerova L. Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells. Cell Commun Signal. 2016;14:4.
We thank M. Dubrovcakova, V. Frivalska for the excellent technical assistance and B. Smolková, PhD. for help with statistic analysis. We thank L. Skirkova for technical help with vector preparation. This study was supported by the VEGA grants No.2/0087/15 (L.K.) and 2/0171/13 (M.M.). This work was supported by the Slovak Research and Development Agency under the contract No.APVV-0230-11 and No.APVV-0052-12. The experiments on the IncuCyte ZOOM™ were enabled with the kind help and the financial support from the Cancer Research Foundation.
Concept, design and development of methodology: LK, MM; RFP vector design and RFP-MSC preparation ST, ED; acquisition of data LK, SS, MM, LT, LD, JG; analysis and interpretation of data LK, MM, SS, LT, LD, JG; writing of the manuscript and review: LK, SS; patient material and patient management: MB. All authors read and approved the final manuscript.
The online version of the original article can be found under doi:10.1186/s12964-016-0127-0.
About this article
Cite this article
Skolekova, S., Matuskova, M., Bohac, M. et al. Erratum to: Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells. Cell Commun Signal 14, 7 (2016). https://doi.org/10.1186/s12964-016-0130-5